Home › Funds › Manulife Financial › PCVX
Manulife Financial position in PCVX
VAXCYTE INC · Health Care
Latest position (Q2 2026)108.50K sh
Reported value held$6.31M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 21.38K | $542.00K | New |
| Q4 2021 | 21.48K | $511.00K | Hold |
| Q1 2022 | 17.51K | $423.00K | Reduce |
| Q2 2022 | 20.76K | $452.00K | Add |
| Q3 2022 | 20.74K | $498.00K | Hold |
| Q4 2022 | 28.50K | $1.37M | Add |
| Q1 2023 | 28.96K | $1.09M | Add |
| Q2 2023 | 81.69K | $4.08M | Add |
| Q3 2023 | 92.82K | $4.73M | Add |
| Q4 2023 | 105.07K | $6.60M | Add |
| Q1 2024 | 119.08K | $8.13M | Add |
| Q2 2024 | 131.75K | $9.95M | Add |
| Q3 2024 | 157.02K | $17.94M | Add |
| Q4 2024 | 158.53K | $12.98M | Add |
| Q1 2025 | 153.15K | $5.78M | Reduce |
| Q2 2025 | 208.01K | $6.76M | Add |
| Q3 2025 | 136.87K | $4.93M | Reduce |
| Q4 2025 | 108.44K | $4.97M | Reduce |
| Q1 2026 | 86.37K | $5.02M | Reduce |
| Q2 2026 | 108.50K | $6.31M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PCVX
- Fidelity Management & Research (FMR) 20.85M sh · $1.21B · Q2 2026
- Janus Henderson Group 16.58M sh · $960.23M · Q1 2026
- BlackRock Inc 12.07M sh · $701.52M · Q2 2026
- Vanguard Group 12.19M sh · $562.63M · Q4 2025
- Wellington Management Group 7.00M sh · $407.00M · Q2 2026
- Geode Capital Management 3.46M sh · $201.13M · Q2 2026
- D. E. Shaw & Co 1.90M sh · $110.56M · Q2 2026
- Maverick Capital 1.61M sh · $93.78M · Q2 2026
- Charles Schwab Investment Management 1.46M sh · $85.15M · Q2 2026
- Goldman Sachs Group 1.38M sh · $79.98M · Q2 2026
- Northern Trust Corp 1.28M sh · $74.42M · Q2 2026
- Norges Bank Investment Management 1.25M sh · $72.42M · Q2 2026